Bayer has made significant updates to its Technology Use Agreement (TUG) that include a class action waiver. This means that customers who wish to participate in class action lawsuits against Bayer must give up their right to do so and instead opt for individual arbitration in case of disputes. Jacob Prather, Bayer’s stewardship lead, announced these changes earlier this year and stated that they were aimed at ensuring the success of customers who rely on the company’s technologies.
According to Prather, the updates are intended to preserve the value of Bayer’s technologies so that they can benefit growers for generations to come. In addition to the class action waiver, there are several other changes to the TUG that growers should be aware of. These updates have sparked debate among legal experts and consumer advocacy groups, with some believing that they may limit customers’ ability to seek redress for legitimate grievances while others view them as a practical way to simplify dispute resolution processes.
Prather reassures customers that they can still pursue individual arbitration even if they have accepted the class action waiver. To better understand the terms of the agreement, growers can visit AgCelerate.com or tug.bayer.com. It is recommended that growers consult state agriculture laws or regulations to ensure they meet any prerequisites for maintaining legal actions, such as arbitration.
The introduction of a class action waiver in the TUG has raised concerns among legal experts and consumer advocacy groups about limiting customers’ ability to seek redress for legitimate grievances.
However, Prather insists that these updates are necessary for ensuring the success of Bayer’s technologies and preserving their value for future generations of growers.
Growers who want to understand more about these changes can visit AgCelerate.com or tug.bayer.com.
It is important for growers to consult state agriculture laws or regulations before proceeding with any legal actions under the updated TUG agreement.
Overall, these updates reflect Bayer’s commitment towards providing its customers with effective dispute resolution mechanisms while also protecting its intellectual property rights over its technology products.
